Established in 2001, Immutep is headquartered in Sydney, New South Wales. They are a biotechnology company working in the field of cancer immunotherapy.
View Top Employees from Immutep S.AWebsite | http://www.immutep.com |
Ticker | IMMP |
Revenue | $4 million |
Funding | $7 million |
Employees | View employees |
Address | Grosvenor Pl Level 12 225 George St, Sydney, New South Wales 2000, AU |
Phone | +61 2 8315 7003 |
Fax | +61 2 8569 1880 |
Industry | Business Services General, Business Services |
Competitors | Argos Therapeutics, Inc. (NASDAQ: ARGS), Cel-Sci, Kiadis Pharma, NEOVACS, OSE Immunotherapeutics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 5419 Companies, NAICS Code 32541 Companies, NAICS Code 54199 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies |
Looking for a particular Immutep S.A employee's phone or email?
The Immutep S.A annual revenue was $4 million in 2024.
Immutep S.A is based in Sydney, New South Wales.
The NAICS codes for Immutep S.A are [32, 325414, 3254, 5419, 32541, 54199, 54, 325, 541].
The SIC codes for Immutep S.A are [873, 87].